Just recently, BioNTech SE made an announcement that it is considering the building of the factories for malaria and tuberculosis vaccine production in Rwanda and Senegal cities. Looking at the chart for the last 5 days, we can see the small fall of the stock from $384.40 on August 23 to $355.70 on August 27. The decline of the BNTX is accompanied by high volatility. Future malaria and tuberculosis vaccines will be based on PNA messenger which is also used in the COVID-19 vaccine.
Agneta is still enjoying her trips to Asia and Africa while she works at Own Snap as an author and reporter. Very soon she will settle somewhere in Europe and run her startup enterprise.